The estimated Net Worth of Kathy H. Gaddes is at least 5.35 百万$ dollars as of 21 February 2020. Ms Gaddes owns over 22,140 units of Amerisource Bergen stock worth over 5,227,699$ and over the last 8 years she sold ABC stock worth over 120,060$.
Ms has made over 12 trades of the Amerisource Bergen stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 22,140 units of ABC stock worth 1,674,005$ on 21 February 2020.
The largest trade she's ever made was exercising 22,140 units of Amerisource Bergen stock on 21 February 2020 worth over 1,674,005$. On average, Ms trades about 2,351 units every 57 days since 2016. As of 21 February 2020 she still owns at least 29,046 units of Amerisource Bergen stock.
You can see the complete history of Ms Gaddes stock trades at the bottom of the page.
Kathy H. Gaddes is the Exec. VP & Chief Compliance Officer at Amerisource Bergen.
Ms Gaddes is 58, she's been the Exec. VP & Chief Compliance Officer of Amerisource Bergen since . There are 13 older and 8 younger executives at Amerisource Bergen. The oldest executive at Amerisource Bergen Corp. is Jane Henney, 72, who is the Lead Independent Director.
Kathy's mailing address filed with the SEC is 1300 MORRIS DRIVE, , CHESTERBROOK, PA, 19428.
Over the last 21 years, insiders at Amerisource Bergen have traded over 4,389,593,610$ worth of Amerisource Bergen stock and bought 18,610 units worth 1,659,872$ . The most active insiders traders include Boots Alliance, Inc.Walgree...、Lon R Greenberg、Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of 13,111,903$. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth 813,987$.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: